Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
25,920
+12,894
+99% +$596K 0.21% 108
2026
Q1
$639K Buy
+13,026
New +$606K 0.16% 132
2025
Q2
Sell
-28,149
Closed -$1.3M 572
2025
Q1
$1.3M Buy
28,149
+18,722
+199% +$783K 0.25% 88
2024
Q4
$355K Buy
+9,427
New +$366K 0.07% 270

Other funds holding EXC

111 Capital's EXC Position: Q2 2026 in Review

111 Capital increased its Exelon (EXC) stake by 99% in Q2 2026, buying an estimated $596K and bringing the position to 25,920 shares worth $1.21M. The position accounts for 0.21% of the portfolio, ranked #108.

111 Capital first reported a position in EXC in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.3M in Q1 2025. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • 111 Capital held 25,920 shares of Exelon worth $1.21M as of Q2 2026.
  • 111 Capital bought 12,894 Exelon shares in Q2 2026, an estimated $596K.
  • Exelon made up 0.21% of 111 Capital's portfolio in Q2 2026, its #108 holding.
  • 111 Capital first reported a position in Exelon in Q4 2024 and has held it in 4 quarters since.
  • 111 Capital's Exelon position peaked at $1.3M in Q1 2025.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.